Regulatory Strategy & Submissions
Live Webinar with Q&A | Tuesday, November 17, 2026 11:00 AM – 12:00PM ET / 5:00-6:00 PM CEST · 45 minutes + 15 Q&A
How Patient Access Services Assist in Market Access Strategy
Patient access services are central to commercialization. Benefit verification, prior authorization support, onboarding, and field education reduce friction for clinicians,...
ISO 14155 vs ICH GCP: Which Standard Governs Your Combination Product Trial?
ISO 14155 vs ICH GCP explained: what each standard governs and why combination products often need device GCP and drug GCP at once.
Borderline Products: When You Need an IND in the US and a Notified Body in the EU
You have one product, and two regulators are about to describe it in two different ways. Borderline products, the kind that sit on the line…
IVD 2026: What Changed, and What You Still Have to Do
2026 has been the most consequential year for US diagnostics in a decade, and the two developments that defined it...
The Payment Gap in Molecular Imaging Just Changed. Is Your Coding and Coverage Strategy Keeping Up?
Get Your Copy Now Name(Required) First Name Last Name Company name(Required)Email(Required) Consent(Required) By checking here, you agree for the information...
Endospan TRIOMPHE Case Study
Get Your Copy Now Name(Required) First Name Last Name Company name(Required)Email(Required) Consent(Required) By checking here, you agree for the information...
The Future of MedTech Trials
Streamline Your EU MDR Compliance With Avania
Get Your Copy Now Name(Required) First Name Last Name Company name(Required)Email(Required) Consent(Required) By checking here, you agree for the information...